The present study identified the following prognostic factors of breast cancer outcomes for patients: HER2-positive subtype, TNBC, pCR, Ki-67 > 25, higher pathologic nodal stage, later clinical staging, and treatment period. The gene discussed is MKI67; the disease is breast carcinoma.